Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Rheumatoid arthritis

Diagnosis of RA—we have a dream

Nature Reviews Rheumatology volume 9, pages 202–204 (2013)Cite this article

Subjects

It is never too early to tackle arthritis. Currently, classification of rheumatoid arthritis is based on the clinical assessment of synovitis. The question is: should we consider 'clinical synovitis' the gold standard for clinical decision making, or should we try something more?

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Power Doppler ultrasonography imaging features of synovitis.

References

  1. Willemze, A., Toes, R. E., Huizinga, T. W. & Trouw, L. A. New biomarkers in rheumatoid arthritis. Neth. J. Med. 70, 392–399 (2012).

    CAS  PubMed  Google Scholar 

  2. Naredo, E. et al. Assessment of inflammatory activity in rheumatoid arthritis: a comparative study of clinical evaluation with grey scale and power Doppler ultrasonography. Ann. Rheum. Dis. 64, 375–381 (2005).

    Article  CAS  Google Scholar 

  3. Nakagomi, D. et al. Ultrasound can improve the accuracy of the 2010 ACR/EULAR classification criteria for rheumatoid arthritis to predict methotrexate requirement. Arthritis Rheum. http://dx.doi.org/10.1002/art.37848.

  4. Aletaha, D. et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 62, 2569–2581 (2010).

    Article  Google Scholar 

  5. Salaffi, F. et al. A clinical prediction rule combining routine assessment and power Doppler ultrasonography for predicting progression to rheumatoid arthritis from early-onset undifferentiated arthritis. Clin. Exp. Rheumatol. 28, 686–694 (2010).

    CAS  PubMed  Google Scholar 

  6. Filer, A. et al. Utility of ultrasound joint counts in the prediction of rheumatoid arthritis in patients with very early synovitis. Ann. Rheum. Dis. 70, 500–507 (2011).

    Article  Google Scholar 

  7. Torp-Pedersen, S. T. & Terslev, L. Settings and artefacts relevant in colour/power Doppler ultrasound in rheumatology. Ann. Rheum. Dis. 67, 143–149 (2008).

    Article  CAS  Google Scholar 

  8. Grassi, W., Gaywood, I., Pande, I. & Filippucci, E. From DAS 28 to SAS 1. Clin. Exp. Rheumatol. 30, 649–651 (2012).

    Google Scholar 

  9. Gutierrez, M., Filippucci, E., Salaffi, F., Di Geso, L. & Grassi, W. Differential diagnosis between rheumatoid arthritis and psoriatic arthritis: the value of ultrasound findings at metacarpophalangeal joints level. Ann. Rheum. Dis. 70, 1111–1114 (2011).

    Article  Google Scholar 

  10. Filippucci, E., Riveros, M. G., Georgescu, D., Salaffi, F. & Grassi, W. Hyaline cartilage involvement in patients with gout and calcium pyrophosphate deposition disease. An ultrasound study. Osteoarthritis Cartilage 17, 178–181 (2009).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Università Politecnica delle Marche, Clinica Reumatologica, Via dei Colli 52, Jesi, 60035, Ancona, Italy

    Walter Grassi & Emilio Filippucci

Authors
  1. Walter Grassi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Emilio Filippucci
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Walter Grassi.

Ethics declarations

Competing interests

W. Grassi declares that he has received financial/grant support from, acted as a consultant for and received speakers' honoraria from AbbVie, Bristol-Myers Squibb, Esaote, GE Medical Systems, MSD, Pfizer, Roche and UCB Pharma, has acted as a consultant for and received speakers' honoraria from Menarini, and has acted as a consultant for Savient. E. Filippucci declares that he has received speakers' honoraria from Abbott, AbbVie, Bristol-Myers Squibb, Esaote, MSD, Pfizer, Schering-Plough and UCB Pharma and has acted as a consultant for Bristol-Myers Squibb.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Grassi, W., Filippucci, E. Diagnosis of RA—we have a dream. Nat Rev Rheumatol 9, 202–204 (2013). https://doi.org/10.1038/nrrheum.2013.39

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrrheum.2013.39

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing